Business Wire

FL-FELD-ENTERTAINMENT

Share
New Cancer Research Funding Effort Announced by Feld Entertainment and Primary Children’s Hospital

The Feld Family, owners of Feld Entertainment, Inc., the parent company of Ringling Bros. and Barnum & Bailey ® and the Ringling Bros. Center for Elephant Conservation ® , announced yesterday a new funding effort with Intermountain Primary Children’s Hospital (PCH) and University of Utah Department of Pediatrics oncologist and Huntsman Cancer Institute investigator Dr. Joshua Schiffman. The fundraising commitment comes on the heels of new pediatric cancer research findings published in the Journal of American Medical Association (JAMA) by Dr. Schiffman.

This Smart News Release features multimedia. View the full release here: http://www.businesswire.com/news/home/20151009005379/en/

Feld Entertainment released today an accompanying video package that describes the research. The video can be seen here .

Dr. Schiffman and the team from Primary Children’s Hospital, the Department of Pediatrics, and Huntsman Cancer Institute, all in Salt Lake City, Utah, are studying why there is such a low incidence of cancer in elephants, what makes this cancer resistance possible in elephants and not in humans, and how this may correlate to new treatments for pediatric cancers.

More than 16,000 children and teenagers are diagnosed with cancer every year in the United States; meanwhile elephants experience almost no cancer over their lifetimes. Dr. Schiffman; Dr. Dennis Schmitt, Ringling Bros. and Barnum & Bailey Chair of Veterinary Services and Director of Research; and Dr. Wendy Kiso, Ringling Bros. Center for Elephant Conservation Research and Conservation Scientist; and other scientific collaborators on their team; recently confirmed that elephants rarely develop cancer with a mortality rate of less than 5 percent compared to up to 25 percent in humans. Looking at the elephant genome, they described that elephants have 40 copies of a tumor suppressor gene named TP53 compared to only two copies in humans.

Working with Utah's Hogle Zoo and the Ringling Bros. Center for Elephant Conservation , Dr. Schiffman and colleagues studied the response of elephant blood to DNA damaging agents and discovered that elephant cells undergo cell death more rapidly compared to human cells. Dr. Schiffman believes this may be why elephants develop less cancer than humans. The study’s full findings have been published in the new edition of the Journal of American Medical Association .

Applying the translational research around cancer – the findings from the basic science that enhance human health and well-being by improving medical and nursing practices and creating meaningful health outcomes – could pave the way for an entirely new frontier of cancer research and treatment, from the laboratory bench to the bedside.

The Feld Family is forming the Ringling Bros. Children’s Fund™ as an element of their ongoing philanthropy through the Feld Family Foundation to support children’s charities. As part of the partnership with Primary Children’s Hospital, the Department of Pediatrics, and Dr. Schiffman, the Ringling Bros. Children’s Fund  and Ringling Bros. and Barnum & Bailey will be donating more than $1 million to support cancer research and to care for children.

In the next 50 cities Ringling Bros. and Barnum & Bailey  visits, Ringling Bros. will donate $10,000 to a local children’s hospital or treatment center and the Ringling Bros. Children’s Fund  will match each donation with an additional $10,000 donation to the Primary Children’s Hospital Foundation to support the PCH Pediatric Cancer Research Program. This program, which helped support the elephant research, focuses on novel approaches to prevention, diagnosis, and improving the value of pediatric cancer care.

Additional information on Ringling Bros. and Barnum & Bailey and the Ringling Bros. Center for Elephant Conservation , the partnership and information on how families can donate to the research can be found online at www.ringling.com and www.ringlingelephantcenter.com .

EDITOR’S NOTE: B-roll to support the story is attached and also here .

About Feld Entertainment

Feld Entertainment is the worldwide leader in producing and presenting live touring family entertainment experiences that lift the human spirit and create indelible memories, with 30 million people in attendance at its shows each year. Feld Entertainment's productions have appeared in more than 75 countries and on six continents to date and include Ringling Bros. and Barnum & Bailey ® , Monster Jam ® , Monster Energy Supercross , AMSOIL Arenacross , Disney On Ice Presented by Stonyfield YoKids Organic Yogurt, Disney Live! Presented by Stonyfield YoKids Organic Yogurt and Marvel Universe LIVE! More information about Feld Entertainment is available online at www.feldentertainment.com . More information on the Ringling Bros. Center for Elephant Conservation is available at www.ringlingelephantcenter.com .

About Primary Children’s Hospital

Primary Children's Hospital is the only full-service children's hospital for Utah, Idaho, Wyoming, Nevada, and Montana providing care for children with the most complex injury and illness, including those who require heart, liver, kidney and bone marrow transplants. Primary Children’s is the only Level 1 Pediatric Trauma Center in the Intermountain West. It is owned by Intermountain Healthcare, a not-for-profit healthcare system, and is affiliated with the University of Utah School of Medicine, which brings together research, training and excellent care to provide the best health care for children. Donations are administered by Primary Children’s Hospital Foundation, a separately incorporated public charity under IRS Code 501(c)(3). The foundation supports the hospital’s goals of providing the highest level of pediatric care in an atmosphere of love and concern.

About the University of Utah Department of Pediatrics

The Department of Pediatrics is the second largest department in the University of Utah School of Medicine and one of the largest pediatric departments in the country. There are 270 faculty members in the department with a fairly equal distribution of men and women, and we have the greatest number of tenured female faculty in the School of Medicine. The department is comprised of 22 medical divisions and programs operating in conjunction with four key enterprises: Education, Research, Clinical, and Academic. Divisions provide a full spectrum of specialty and subspecialty pediatric services for children throughout the Intermountain West.

About Huntsman Cancer Institute at the University of Utah

Huntsman Cancer Institute (HCI) is one of the world’s top academic research and cancer treatment centers. HCI manages the Utah Population Database  - the largest genetic database in the world, with more than 16 million records linked to genealogies, health records, and vital statistics. Using this data, HCI researchers have identified several cancer-causing genes, including the genes responsible for melanoma, colon and breast cancer, and paraganglioma. HCI is a member of the National Comprehensive Cancer Network  (a 26-member alliance of the world's leading cancer centers) and is a National Cancer Institute-Designated Comprehensive Cancer Center . HCI treats patients with all forms of cancer and operates several high-risk clinics that focus on melanoma and breast, colon, and pancreas cancers. The HCI Cancer Learning Center for patient and public education contains one of the nation's largest collections of cancer-related publications. The institute is named after Jon M. Huntsman , a Utah philanthropist, industrialist, and cancer survivor.

Contact:

Feld Entertainment
Stephen Payne, 703-749-5505
spayne@feldinc.com
or
Primary Children’s Hospital
Bonnie Midget, 801-662-6590
bonnie.midget@imail.org

About Business Wire

Business Wire
Business Wire
101 California Street, 20th Floor
CA 94111 San Francisco

http://businesswire.com

Subscribe to releases from Business Wire

Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.

Latest releases from Business Wire

CCM Biosciences Announces Presentation of Data on its First-In-Class AML Drug Program at ASCO 202520.5.2025 22:30:00 CEST | Press release

Company’s AML drug program is focused on both newly diagnosed and relapsed/refractory FLT3-positive AML, overcoming major forms of resistance to FDA-approved FLT3 inhibitors, and outperforms other investigational inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its next-generation FLT3 inhibitor drug program for acute myeloid leukemia (AML) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. Acute Myeloid Leukemia (AML) is the most severe form of leukemia with few treatment options, and a malignancy frequently driven by mutations in the FMS-like tyrosine kinase 3 (FLT3) gene. The FLT3 internal tandem duplication (ITD) and tyrosine kinase domain (TKD) mutations, particularly D835 and F691, appear in approximately 30% of AML patients, often leading to poor prognosis and resistance to exi

IonQ Partners with Sweden’s Einride to Develop Quantum Supply Chain and Quantum-Enhanced Logistics for Autonomous Driving Solutions20.5.2025 22:05:00 CEST | Press release

IonQ and Einride will collaborate to develop quantum solutions for fleet routing, logistics optimization, and supply chain solutionsIonQ’s investment will grow its European presence and reinforce commitment to building a quantum economy in Sweden and the European market IonQ (NYSE: IONQ), a leading commercial quantum computing and networking company, today announced an investment partnership with Einride, a leading global freight mobility company that provides digital, electric, and autonomous technology to explore how quantum computing can drive the next generation of fleet optimization and logistics. Together, IonQ and Einride will develop quantum applications that address large-scale routing and scheduling problems that have traditionally challenged classical computing. By combining IonQ’s advanced quantum systems with Einride’s expertise in autonomous fleet logistics, the two companies will work to unlock new levels of efficiency, reliability, and sustainability for the global frei

CCM Biosciences Announces Presentation of Data on its First-In-Class NSCLC Drug Program at ASCO 202520.5.2025 21:26:00 CEST | Press release

Company’s NSCLC drug program is focused on overcoming both mutational and non-mutational resistance to 3rd-generation EGFR inhibitors and outperforms other investigational 4th-generation inhibitors in a wide range of drug resistance models. CCM Biosciences, a diversified pharmaceutical discovery and development company, today announced the upcoming presentation of its 4th-generation EGFR inhibitor drug program for non-small cell lung cancer (NSCLC) at the 2025 Annual Conference of the American Society of Clinical Oncology (ASCO), taking place May 30 to June 3 in Chicago. NSCLC, which accounts for 80% of lung cancer, is the most common cause of cancer death worldwide. Epidermal growth factor receptor (EGFR)-activating mutations (Del19 or L858R) are major oncogenic drivers of NSCLC. EGFR-positive NSCLC accounts for approximately 30% of all diagnosed cases of NSCLC (a similar market size to PD-L1-positive NSCLC, which is addressed by the world’s top-selling drug, Keytruda®). The current s

NielsenIQ's Chief Technology Officer Mohit Kapoor Named Executive of the Year at Global Tech & AI Awards for Leading NIQ’s AI-Driven Tech Transformation20.5.2025 21:24:00 CEST | Press release

NielsenIQ (NIQ) is proud to announce that Mohit Kapoor, Chief Technology Officer, was named Executive of the Year at the inaugural Global Tech & AI Awards. This honor recognizes Mohit's exceptional leadership and visionary contributions to the tech industry, particularly in the realm of AI-powered consumer intelligence. "I am deeply honored to receive the Executive of the Year award at the Global Tech & AI Awards. This recognition is a testament to the incredible work and dedication of the entire NielsenIQ team,” said Mohit Kapoor, Chief Technology Officer, NIQ. “Together, we have redefined consumer and retail intelligence, leveraging AI to deliver unparalleled insights and drive meaningful change in the industry." Under Mohit's leadership, NIQ has adopted an AI-powered approach to its ambitious digital transformation which included a $400 million technology investment and the migration of its global client base onto Discover– a unified, cloud-based platform that seamlessly integrates

Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco20.5.2025 21:08:00 CEST | Press release

As part of the implementation of the commitments made in the joint declaration between His Majesty King Mohammed VI, may God Assist Him, and His Highness Sheikh Mohamed bin Zayed Al Nahyan, TAQA Morocco, in partnership with Nareva and the Mohammed VI Fund for Investment, has signed three memorandums of understanding and related development agreements with the Government of Morocco and ONEE. These agreements cover the development of structuring projects in the power, water and renewable energy sectors. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20250520313620/en/ Strategic Partnership Between the Government of Morocco and TAQA Morocco, Nareva, ONEE and the Mohammed VI Investment Fund to Develop Key Power and Water Infrastructures in the Kingdom of Morocco (Photo: AETOSWire) The program aims to strengthen the Kingdom's water and energy sovereignty through the development of flexible natural gas-based power generation capacit

In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.

Visit our pressroom
World GlobeA line styled icon from Orion Icon Library.HiddenA line styled icon from Orion Icon Library.Eye